Back to mobile site

Citizens Downgrades Foghorn Therapeutics (FHTX) to Market Perform

October 1, 2026 2:55 PM EDT Send to a Friend
Citizens analyst Silvan Tuerkcan downgraded Foghorn Therapeutics (NASDAQ: FHTX) from Market Outperform to Market Perform.The analyst comments "Foghorn Therapeutics and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login